Thomas J Elardo, DPM
Podiatry · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 30
- 9 carriers
- Office
- 1
Offices
1 location · Bay Area Foot Care Inc · 127 clinicians in this group
Hospitals listed: Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
30 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Elardo’s office at (408) 358-6234 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
30 of 30 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Surgery centers they own
- Silicon Valley Surgery Center, LPAmbulatory Surgery Center · Campbell, CA2.24% owner since 1999 · accredited by AAAHCAccreditation Renewed4 inspections, 1 with deficiencies · last 2024-09-16
- Silicon Valley Surgery Center, LP - BascomAmbulatory Surgery Center · Campbell, CA2.24% owner since 1999 · accredited by AAAHCAccreditation RenewedNo inspections published
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$325,659
Medicare paid this office $325,659 for 554 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 313 | $50,820 | $81 |
| Return visit (30+ min) | 279 | $49,563 | $113 |
| Removal of noncancer thickened skin growth, 2-4 growths | 112 | $21,632 | $81 |
| Removal of fingernails or toenails, 6 or more nails | 152 | $20,668 | $42 |
| X-ray of foot, minimum of 3 views | 229 | $16,081 | $34 |
See all 30 services
| Short return visit (20+ min) | 313 | $50,820 | $81 |
| Return visit (30+ min) | 279 | $49,563 | $113 |
| Removal of noncancer thickened skin growth, 2-4 growths | 112 | $21,632 | $81 |
| Removal of fingernails or toenails, 6 or more nails | 152 | $20,668 | $42 |
| X-ray of foot, minimum of 3 views | 229 | $16,081 | $34 |
| New patient visit (45+ min) | 100 | $12,890 | $129 |
| Correction of toe joint deformity | 27 | $12,670 | $222 |
| Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | 27 | $9,966 | $27 |
| Long return visit (40+ min) | 57 | $9,637 | $153 |
| Simple separation of fingernail or toenail from nail bed, first nail | 67 | $8,722 | $110 |
| Therapy procedure using manual technique, each 15 minutes | 27 | $8,514 | $19 |
| Removal of noncancer thickened skin growth, 1 growth | 67 | $7,055 | $71 |
| Destruction of skin growth, 1-14 growths | 51 | $6,480 | $103 |
| Correction of bunion with alignment correction of midfoot bone toward toe area | 13 | $6,311 | $485 |
| Test or measurement for functional capacity, each 15 minutes | 103 | $5,866 | $28 |
| Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | 22 | $5,413 | $23 |
| New patient visit (30+ min) | 55 | $5,023 | $91 |
| Aspiration and/or injection of fluid from medium joint | 72 | $4,247 | $42 |
| Injection into tendon or ligament | 46 | $2,826 | $48 |
| Evaluation for physical therapy, typically 20 minutes | 26 | $2,640 | $98 |
| Removal of tissue from wound, 20.0 sq cm or less | 16 | $2,416 | $93 |
| Complete ultrasound scan of joint | 43 | $2,206 | $42 |
| Injection of anesthetic and/or steroid drug into foot nerve | 28 | $1,483 | $45 |
| X-ray of ankle, minimum of 3 views | 24 | $1,250 | $37 |
| Simple separation of fingernail or toenail from nail bed, each additional nail | 18 | $658 | $33 |
| Ultrasonic guidance for needle placement | 11 | $565 | $51 |
| Aspiration and/or injection of fluid from small joint | 11 | $498 | $45 |
| Removal of fingernails or toenails, 1-5 nails | 12 | $301 | $25 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 130 | $148 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 137 | $70 | None |
Procedures Medicare counted
| Removal of nail tissue | 641 | More than 86% of doctors who do this |
| Removal of skin lesions | 73 | More than 74% of doctors who do this |
| Removal of tissue | 64 | More than 81% of doctors who do this |
| Removal or shaving of skin growth | 410 | More than 94% of doctors who do this |
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
554 Original Medicare patients in 2024. Average age 77 · Women 64% · Also on Medicaid 3% · Health risk score 1.05. At or below the middle of the specialty; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 75% · Diabetes 25% · Coronary heart disease 25% · Atrial fibrillation 20% · Cancer 19% · Chronic kidney disease 16% · Depression 16% · Heart failure 12% · Stroke 8% · COPD 7% · Dementia 5%.
The office billed $1,476,808, Medicare allowed $435,784 and paid $325,659; for 6,860 services of 93 kinds; $3,092 of it was for drugs given in the office and $322,567 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 554 | 6,860 | 77 | 1.05 | $1,476,808 | $325,659 |
| 2023 | 547 | 5,269 | 77 | 1.08 | $1,322,627 | $295,521 |
| 2022 | 537 | 3,548 | 77 | 1.14 | $914,722 | $268,270 |
| 2021 | 542 | 3,058 | 76 | 1.08 | $488,763 | $245,153 |
| 2020 | 535 | 3,041 | 76 | 1.16 | $506,168 | $230,112 |
| 2019 | 571 | 3,828 | 76 | 1.18 | $457,809 | $205,720 |
| 2018 | 555 | 3,713 | 77 | 1.20 | $449,961 | $214,201 |
| 2017 | 516 | 3,520 | 76 | 1.19 | $443,429 | $199,343 |
| 2016 | 428 | 2,845 | 76 | 1.20 | $357,848 | $166,894 |
| 2015 | 381 | 2,361 | 76 | 1.22 | $326,654 | $151,221 |
| 2014 | 333 | 2,126 | 76 | 1.16 | $237,182 | $124,009 |
| 2013 | 374 | 2,440 | 75 | 1.21 | $315,442 | $152,350 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 31 services
| Short return visit (20+ min) | 329 | $49,874 | $79 |
| Return visit (30+ min) | 194 | $30,291 | $113 |
| Removal of noncancer thickened skin growth, 2-4 growths | 128 | $26,665 | $79 |
| Removal of fingernails or toenails, 6 or more nails | 164 | $21,661 | $41 |
| X-ray of foot, minimum of 3 views | 200 | $13,345 | $35 |
| Therapy procedure using manual technique, each 15 minutes | 35 | $11,033 | $19 |
| New patient visit (45+ min) | 77 | $10,976 | $143 |
| Correction of toe joint deformity | 20 | $10,301 | $224 |
| Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | 26 | $10,250 | $24 |
| Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | 21 | $9,745 | $28 |
| Long return visit (40+ min) | 47 | $8,488 | $157 |
| Simple separation of fingernail or toenail from nail bed, first nail | 63 | $7,186 | $107 |
| New patient visit (30+ min) | 58 | $5,943 | $102 |
| Injection into tendon or ligament | 69 | $4,990 | $50 |
| Removal of noncancer thickened skin growth, 1 growth | 41 | $4,822 | $74 |
| Destruction of skin growth, 1-14 growths | 37 | $4,739 | $110 |
| Removal of tissue from wound, 20.0 sq cm or less | 27 | $4,134 | $101 |
| Ultrasound of leg arteries or artery grafts | 15 | $3,764 | $251 |
| Evaluation for physical therapy, typically 20 minutes | 33 | $3,744 | $99 |
| Biopsy of fingernail or toenail | 16 | $1,866 | $104 |
| Complete ultrasound study of arm and leg arteries | 15 | $1,622 | $108 |
| Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 22 | $1,550 | $8 |
| X-ray of ankle, minimum of 3 views | 28 | $1,387 | $37 |
| Injection of anesthetic and/or steroid drug into foot nerve | 23 | $1,333 | $44 |
| Aspiration and/or injection of fluid from small joint | 14 | $701 | $44 |
| X-ray of foot, 2 views | 21 | $659 | $27 |
| Aspiration and/or injection of fluid from medium joint | 18 | $620 | $33 |
| Complete ultrasound scan of joint | 11 | $567 | $52 |
| Simple separation of fingernail or toenail from nail bed, each additional nail | 13 | $432 | $33 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 112 | $138 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 79 | $41 | None |
2022: 25 services
| Short return visit (20+ min) | 369 | $66,380 | $82 |
| Removal of noncancer thickened skin growth, 2-4 growths | 145 | $31,899 | $80 |
| Removal of fingernails or toenails, 6 or more nails | 190 | $24,931 | $41 |
| Return visit (30+ min) | 109 | $14,867 | $116 |
| X-ray of foot, minimum of 3 views | 202 | $13,896 | $35 |
| New patient visit (30+ min) | 118 | $11,410 | $97 |
| Correction of toe joint deformity | 20 | $11,031 | $208 |
| Ultrasound of leg arteries or artery grafts | 31 | $8,372 | $262 |
| Simple separation of fingernail or toenail from nail bed, first nail | 63 | $7,541 | $111 |
| Removal of deep implant from bone | 12 | $7,261 | $559 |
| Removal of noncancer thickened skin growth, 1 growth | 40 | $4,669 | $72 |
| Injection into tendon or ligament | 64 | $4,343 | $47 |
| Destruction of skin growth, 1-14 growths | 32 | $3,828 | $109 |
| Complete ultrasound study of arm and leg arteries | 30 | $3,399 | $110 |
| Removal of tissue from wound, 20.0 sq cm or less | 18 | $2,991 | $100 |
| New patient visit (45+ min) | 17 | $2,679 | $158 |
| Long return visit (40+ min) | 11 | $2,054 | $171 |
| Removal of noncancer thickened skin growth, more than 4 growths | 12 | $1,761 | $93 |
| Injection of anesthetic and/or steroid drug into foot nerve | 12 | $1,196 | $48 |
| Aspiration and/or injection of fluid from medium joint | 17 | $957 | $48 |
| X-ray of ankle, minimum of 3 views | 17 | $832 | $38 |
| X-ray of foot, 2 views | 16 | $542 | $30 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 47 | $284 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 52 | $74 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 46 | $17 | None |
2021: 18 services
| Short return visit (20+ min) | 390 | $75,326 | $83 |
| Removal of noncancer thickened skin growth, 2-4 growths | 124 | $29,311 | $79 |
| Removal of fingernails or toenails, 6 or more nails | 176 | $21,699 | $41 |
| New patient visit (30+ min) | 165 | $16,145 | $98 |
| X-ray of foot, minimum of 3 views | 196 | $13,318 | $35 |
| Removal of deep implant from bone | 16 | $10,941 | $576 |
| Simple separation of fingernail or toenail from nail bed, first nail | 69 | $9,147 | $117 |
| Injection into tendon or ligament | 83 | $6,659 | $50 |
| Return visit (30+ min) | 49 | $5,943 | $114 |
| Correction of toe joint deformity | 13 | $5,728 | $220 |
| Correction of bunion with alignment correction of midfoot bone toward toe area | 13 | $5,386 | $414 |
| Destruction of skin growth, 1-14 growths | 36 | $4,501 | $118 |
| Removal of noncancer thickened skin growth, 1 growth | 37 | $3,563 | $67 |
| Removal of tissue from wound, 20.0 sq cm or less | 25 | $3,046 | $95 |
| X-ray of ankle, minimum of 3 views | 23 | $1,143 | $39 |
| Injection of anesthetic and/or steroid drug into foot nerve | 14 | $593 | $37 |
| Simple separation of fingernail or toenail from nail bed, each additional nail | 14 | $517 | $34 |
| X-ray of foot, 2 views | 13 | $393 | $30 |
2020: 19 services
| Short return visit (20+ min) | 370 | $58,643 | $68 |
| Removal of noncancer thickened skin growth, 2-4 growths | 120 | $21,154 | $72 |
| Removal of fingernails or toenails, 6 or more nails | 175 | $19,194 | $41 |
| New patient visit (30+ min) | 180 | $15,577 | $87 |
| X-ray of foot, minimum of 3 views | 199 | $11,832 | $31 |
| Simple separation of fingernail or toenail from nail bed, first nail | 91 | $10,804 | $106 |
| Return visit (30+ min) | 89 | $9,640 | $91 |
| Correction of toe joint deformity | 20 | $9,196 | $214 |
| Removal of deep implant from bone | 13 | $9,093 | $535 |
| Injection into tendon or ligament | 90 | $7,043 | $48 |
| Correction of bunion with alignment correction of midfoot bone toward toe area | 12 | $5,083 | $424 |
| Destruction of skin growth, 1-14 growths | 36 | $4,078 | $105 |
| Removal of tissue from wound, 20.0 sq cm or less | 21 | $3,205 | $100 |
| Removal of noncancer thickened skin growth, 1 growth | 35 | $2,818 | $58 |
| Removal of noncancer thickened skin growth, more than 4 growths | 13 | $2,568 | $76 |
| Injection of anesthetic and/or steroid drug into foot nerve | 21 | $1,867 | $43 |
| X-ray of ankle, minimum of 3 views | 31 | $1,227 | $34 |
| Strapping, unna boot | 12 | $987 | $62 |
| Simple separation of fingernail or toenail from nail bed, each additional nail | 14 | $603 | $34 |
2019: 18 services
| Short return visit (20+ min) | 412 | $59,370 | $64 |
| Removal of fingernails or toenails, 6 or more nails | 189 | $21,692 | $40 |
| Removal of noncancer thickened skin growth, 2-4 growths | 134 | $20,369 | $61 |
| New patient visit (30+ min) | 169 | $14,410 | $85 |
| X-ray of foot, minimum of 3 views | 207 | $10,333 | $28 |
| Return visit (30+ min) | 73 | $8,867 | $95 |
| Simple separation of fingernail or toenail from nail bed, first nail | 79 | $8,752 | $101 |
| Injection into tendon or ligament | 116 | $8,455 | $41 |
| Destruction of skin growth, 1-14 growths | 47 | $5,511 | $104 |
| Removal of noncancer thickened skin growth, 1 growth | 61 | $4,812 | $51 |
| Correction of toe joint deformity | 12 | $4,322 | $227 |
| Removal of tissue from wound, 20.0 sq cm or less | 17 | $2,552 | $77 |
| Injection of anesthetic and/or steroid drug into foot nerve | 26 | $1,436 | $41 |
| X-ray of ankle, minimum of 3 views | 19 | $776 | $31 |
| Simple separation of fingernail or toenail from nail bed, each additional nail | 16 | $489 | $31 |
| Injection, triamcinolone acetonide, preservative free, 1 mg | 50 | $260 | None |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 35 | $189 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 139 | $48 | None |
2018: 19 services
| Short return visit (20+ min) | 396 | $59,125 | $64 |
| Removal of fingernails or toenails, 6 or more nails | 200 | $22,680 | $41 |
| Removal of noncancer thickened skin growth, 2-4 growths | 150 | $21,711 | $54 |
| New patient visit (30+ min) | 177 | $15,794 | $89 |
| X-ray of foot, minimum of 3 views | 174 | $9,023 | $27 |
| Removal of deep implant from bone | 15 | $9,008 | $530 |
| Injection into tendon or ligament | 120 | $8,839 | $42 |
| Return visit (30+ min) | 73 | $8,789 | $96 |
| Simple separation of fingernail or toenail from nail bed, first nail | 68 | $7,528 | $97 |
| Correction of toe joint deformity | 17 | $6,950 | $204 |
| Destruction of skin growth, 1-14 growths | 48 | $5,454 | $105 |
| Removal of noncancer thickened skin growth, 1 growth | 56 | $4,543 | $46 |
| Correction of bunion with alignment correction of midfoot bone toward toe area | 14 | $4,467 | $319 |
| Removal of tissue from wound, 20.0 sq cm or less | 25 | $3,588 | $73 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 127 | $1,154 | None |
| X-ray of ankle, minimum of 3 views | 29 | $1,063 | $30 |
| X-ray of foot, 2 views | 28 | $749 | $25 |
| Simple separation of fingernail or toenail from nail bed, each additional nail | 11 | $318 | $29 |
| Injection, dexamethasone sodium phosphate, 1 mg | 139 | $23 | None |
2017: 18 services
| Short return visit (20+ min) | 369 | $56,030 | $62 |
| Removal of fingernails or toenails, 6 or more nails | 177 | $20,387 | $39 |
| Removal of noncancer thickened skin growth, 2-4 growths | 146 | $19,311 | $52 |
| New patient visit (30+ min) | 156 | $13,730 | $88 |
| Correction of toe joint deformity | 19 | $8,102 | $213 |
| Return visit (30+ min) | 69 | $7,967 | $94 |
| X-ray of foot, minimum of 3 views | 167 | $7,798 | $27 |
| Injection into tendon or ligament | 109 | $7,173 | $39 |
| Simple separation of fingernail or toenail from nail bed, first nail | 67 | $7,018 | $94 |
| Destruction of skin growth, 1-14 growths | 51 | $5,907 | $102 |
| Removal of noncancer thickened skin growth, 1 growth | 51 | $3,954 | $43 |
| Correction of bunion with alignment correction of midfoot bone toward toe area | 11 | $3,820 | $347 |
| Removal of skin and tissue, 20.0 sq cm or less | 11 | $1,905 | $100 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 131 | $1,098 | None |
| X-ray of foot, 2 views | 36 | $1,067 | $24 |
| X-ray of ankle, minimum of 3 views | 19 | $776 | $30 |
| Strapping, unna boot | 14 | $685 | $46 |
| Injection, dexamethasone sodium phosphate, 1 mg | 140 | $22 | None |
2016: 17 services
| Short return visit (20+ min) | 324 | $46,958 | $63 |
| Removal of noncancer thickened skin growth, 2-4 growths | 110 | $15,998 | $53 |
| Removal of fingernails or toenails, 6 or more nails | 144 | $15,683 | $40 |
| New patient visit (30+ min) | 145 | $12,973 | $89 |
| X-ray of foot, minimum of 3 views | 151 | $7,711 | $27 |
| Return visit (30+ min) | 62 | $6,579 | $94 |
| Removal of deep implant from bone | 11 | $6,468 | $539 |
| Injection into tendon or ligament | 81 | $6,360 | $46 |
| Simple separation of fingernail or toenail from nail bed, first nail | 56 | $6,337 | $89 |
| Correction of toe joint deformity | 15 | $6,328 | $204 |
| Destruction of skin growth, 1-14 growths | 43 | $5,196 | $104 |
| Correction of bunion with alignment correction of midfoot bone toward toe area | 13 | $4,901 | $377 |
| Removal of noncancer thickened skin growth, 1 growth | 45 | $2,835 | $43 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 106 | $785 | None |
| X-ray of foot, 2 views | 22 | $572 | $25 |
| Removal of fingernails or toenails, 1-5 nails | 11 | $364 | $30 |
| Injection, dexamethasone sodium phosphate, 1 mg | 113 | $19 | None |
2015: 16 services
| Short return visit (20+ min) | 263 | $39,893 | $64 |
| Removal of fingernails or toenails, 6 or more nails | 127 | $14,467 | $39 |
| Removal of noncancer thickened skin growth, 2-4 growths | 93 | $11,788 | $52 |
| New patient visit (30+ min) | 119 | $11,032 | $93 |
| Correction of bunion with alignment correction of midfoot bone toward toe area | 15 | $6,102 | $381 |
| Correction of toe joint deformity | 15 | $5,879 | $203 |
| X-ray of foot, minimum of 3 views | 105 | $5,507 | $28 |
| Simple separation of fingernail or toenail from nail bed, first nail | 49 | $5,402 | $93 |
| Injection into tendon or ligament | 73 | $5,047 | $49 |
| Destruction of skin growth, 1-14 growths | 34 | $4,435 | $106 |
| Return visit (30+ min) | 39 | $4,341 | $96 |
| Removal of noncancer thickened skin growth, 1 growth | 37 | $2,998 | $41 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 82 | $523 | None |
| X-ray of foot, 2 views | 18 | $506 | $25 |
| Simple separation of fingernail or toenail from nail bed, each additional nail | 12 | $407 | $34 |
| Injection, dexamethasone sodium phosphate, 1 mg | 86 | $14 | None |
2014: 14 services
| Short return visit (20+ min) | 220 | $35,917 | $66 |
| Removal of noncancer thickened skin growth, 2-4 growths | 94 | $15,177 | $55 |
| Removal of fingernails or toenails, 6 or more nails | 125 | $14,950 | $42 |
| New patient visit (30+ min) | 87 | $8,427 | $97 |
| Injection into tendon or ligament | 75 | $5,613 | $49 |
| X-ray of foot, minimum of 3 views | 87 | $5,353 | $32 |
| Simple separation of fingernail or toenail from nail bed, first nail | 41 | $4,219 | $90 |
| Return visit (30+ min) | 33 | $3,442 | $98 |
| Destruction of skin growth, 1-14 growths | 23 | $2,852 | $102 |
| Removal of tissue from wound, 20.0 sq cm or less | 13 | $2,681 | $74 |
| Removal of noncancer thickened skin growth, 1 growth | 29 | $2,661 | $45 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 78 | $537 | None |
| X-ray of foot, 2 views | 11 | $383 | $27 |
| Injection, dexamethasone sodium phosphate, 1 mg | 80 | $13 | None |
2013: 15 services
| Short return visit (20+ min) | 239 | $36,876 | $66 |
| Removal of fingernails or toenails, 6 or more nails | 138 | $16,893 | $41 |
| Removal of noncancer thickened skin growth, 2-4 growths | 91 | $15,250 | $54 |
| New patient visit (30+ min) | 104 | $9,456 | $91 |
| X-ray of foot, minimum of 3 views | 119 | $8,007 | $32 |
| Simple separation of fingernail or toenail from nail bed, first nail | 63 | $6,287 | $91 |
| Correction of toe joint deformity | 14 | $6,255 | $216 |
| Injection into tendon or ligament | 67 | $5,135 | $45 |
| Removal of noncancer thickened skin growth, 1 growth | 34 | $4,311 | $45 |
| Return visit (30+ min) | 33 | $4,106 | $95 |
| Destruction of skin growth, 1-14 growths | 23 | $3,414 | $110 |
| Removal of tissue from wound, 20.0 sq cm or less | 15 | $2,611 | $75 |
| X-ray of foot, 2 views | 13 | $525 | $26 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 67 | $469 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 78 | $11 | None |
Medicaid work
$0 in 2019
Medicaid paid $0 for 20 billed services this clinician did in 2019, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ NURSING FACILITY CARE LOW MDM 20 MINUTES | 20 | $0 |
| 2019 | 20 | 1 | 14 | $0 |
Drugs they prescribed that Part D paid
$11,213
Pharmacies billed $11,213 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 16% of their Part D prescriptions (49 of 317) in 2024. Above the middle of the specialty; the typical podiatry clinician is at 5%.
312 generic and fewer than 11 brand-name prescriptions · $11,213 in drug cost · 36 antibiotic prescriptions to 26 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ketoconazole | 128 | $3,136 | $24 |
| Hydrocodone-Acetaminophen | 40 | $415 | $10 |
| Cephalexin | 26 | $191 | $7 |
| Meloxicam | 41 | $21 | $1 |
| Ibuprofen | 17 | $21 | $1 |
Year by year
| 2024 | 317 | 166 | 16% (49) | None | $11,213 |
| 2023 | 256 | 136 | 19% (49) | None | $14,693 |
| 2022 | 240 | 118 | 18% (42) | None | $10,193 |
| 2021 | 210 | 100 | 24% (51) | None | $7,259 |
| 2020 | 244 | 93 | 20% (49) | None | $10,067 |
| 2019 | 153 | 67 | 21% (32) | None | $4,973 |
| 2018 | 166 | 70 | 25% (41) | 13% | $10,944 |
| 2017 | 137 | 67 | 20% (28) | 26% | $17,452 |
| 2016 | 132 | 66 | 17% (23) | 17% | $19,399 |
| 2015 | 154 | 72 | 13% (20) | None | $47,802 |
| 2014 | 203 | 80 | 16% (33) | None | $32,070 |
| 2013 | 147 | 71 | 18% (26) | 14% | $8,168 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Ketoconazole | 88 | $2,930 | $33 |
| Econazole Nitrate | 11 | $345 | $31 |
| Hydrocodone-Acetaminophen | 37 | $330 | $9 |
| Terbinafine | 14 | $263 | $19 |
| Cephalexin | 16 | $126 | $8 |
| Meloxicam | 16 | $110 | $7 |
| Oxycodone-Acetaminophen | 11 | $88 | $8 |
2022: 5 drugs
| Ketoconazole | 82 | $2,815 | $34 |
| Terbinafine | 22 | $468 | $21 |
| Hydrocodone-Acetaminophen | 36 | $354 | $10 |
| Cephalexin | 14 | $153 | $11 |
| Meloxicam | 23 | $110 | $5 |
2021: 5 drugs
| Ketoconazole | 50 | $2,572 | $51 |
| Terbinafine | 14 | $537 | $38 |
| Hydrocodone-Acetaminophen | 40 | $361 | $9 |
| Nabumetone | 17 | $179 | $11 |
| Gabapentin | 12 | $47 | $4 |
2020: 8 drugs
| Ketoconazole | 27 | $3,406 | $126 |
| Econazole Nitrate | 22 | $635 | $29 |
| Terbinafine | 11 | $381 | $35 |
| Hydrocodone-Acetaminophen | 41 | $308 | $8 |
| Cephalexin | 25 | $279 | $11 |
| Nabumetone | 17 | $189 | $11 |
| Amoxicillin-Clavulanate Potass | 14 | $183 | $13 |
| Gabapentin | 24 | $93 | $4 |
2019: 4 drugs
| Celecoxib | 11 | $1,331 | $121 |
| Neomycin-Polymyxin-Hydrocort | 21 | $257 | $12 |
| Hydrocodone-Acetaminophen | 28 | $245 | $9 |
| Cephalexin | 19 | $161 | $8 |
2018: 4 drugs
| Econazole Nitrate | 23 | $1,746 | $76 |
| Ketoconazole | 12 | $841 | $70 |
| Hydrocodone-Acetaminophen | 36 | $329 | $9 |
| Cephalexin | 23 | $167 | $7 |
2017: 5 drugs
| Jublia | 14 | $8,693 | $621 |
| Econazole Nitrate | 18 | $2,802 | $156 |
| Hydrocodone-Acetaminophen | 14 | $241 | $17 |
| Cephalexin | 25 | $199 | $8 |
| Oxycodone-Acetaminophen | 11 | $84 | $8 |
2016: 4 drugs
| Jublia | 14 | $7,670 | $548 |
| Econazole Nitrate | 33 | $5,807 | $176 |
| Hydrocodone-Acetaminophen | 15 | $422 | $28 |
| Cephalexin | 13 | $93 | $7 |
2015: 4 drugs
| Econazole Nitrate | 48 | $10,398 | $217 |
| Jublia | 13 | $6,453 | $496 |
| Hydrocodone-Acetaminophen | 13 | $369 | $28 |
| Cephalexin | 20 | $110 | $6 |
2014: 4 drugs
| Econazole Nitrate | 43 | $1,968 | $46 |
| Hydrocodone-Acetaminophen | 20 | $674 | $34 |
| Levetiracetam | 12 | $440 | $37 |
| Cephalexin | 12 | $93 | $8 |
2013: 4 drugs
| Econazole Nitrate | 28 | $770 | $27 |
| Gabapentin | 16 | $217 | $14 |
| Cephalexin | 26 | $182 | $7 |
| Hydrocodone-Acetaminophen | 19 | $124 | $7 |
Money from drug and device companies
$1,600 in 2025
| 2025 | 14 | 35 | None | $1,600 |
| 2024 | 13 | 31 | None | $2,055 |
| 2023 | 11 | 33 | None | $2,201 |
| 2022 | 8 | 19 | None | $1,129 |
| 2021 | 3 | 11 | None | $412 |
| 2020 | 11 | 23 | None | $906 |
| 2019 | 15 | 57 | None | $1,884 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Stryker | Ortholoc 2 Lapifuse | $229 | 5 payments
|
| Smith+Nephew | Grafix | $210 | 3 payments
|
| DePuy Synthes Sales | Motoband | $208 | 4 payments
|
| Amgen | Krystexxa | $208 | 6 payments
|
| Abbott Laboratories | Esprit | $190 | 1 payment
|
| Avita Medical Americas | Recell | $135 | 1 payment
|
See all 35 published payments
| Stryker | Meals · 2025-12-12 | Ortholoc 2 Lapifuse | $3 |
| Vertex Pharmaceuticals | Meals · 2025-11-19 | Journavx | $23 |
| DePuy Synthes Sales | Meals · 2025-10-29 | Motoband Cp | $29 |
| Paratek Pharmaceuticals | Meals · 2025-10-21 | Nuzyra | $19 |
| Abbott Laboratories | Meals · 2025-10-07 | Esprit | $190 |
| Treace Medical Concepts | Meals · 2025-10-02 | Percuplasty Tray | $32 |
| Bone Support | Meals · 2025-09-25 | Ceramentbone Void Filler | $16 |
| DePuy Synthes Sales | Meals · 2025-09-12 | Motoband | $36 |
| Stryker | Meals · 2025-09-12 | Ortholoc 2 Lapifuse | $140 |
| Stryker | Meals · 2025-09-09 | Ortholoc 2 Lapifuse | $21 |
| Amgen | Meals · 2025-09-03 | Krystexxa | $27 |
| ANI Pharmaceuticals | Meals · 2025-08-20 | Purified Cortrophin Gel | $25 |
| Amgen | Meals · 2025-08-13 | Krystexxa | $9 |
| ANI Pharmaceuticals | Meals · 2025-08-11 | Purified Cortrophin Gel | $31 |
| Paratek Pharmaceuticals | Meals · 2025-08-05 | Nuzyra | $18 |
| Stryker | Meals · 2025-08-05 | Prostep Mica | $37 |
| Bioventus | Meals · 2025-08-01 | Exogen Ultrasound Bone Healing System | $26 |
| Treace Medical Concepts | Meals · 2025-06-20 | Tmc Psi Cut Guide System | $15 |
| Treace Medical Concepts | Meals · 2025-06-19 | Tmc Psi Cut Guide System | $21 |
| Paratek Pharmaceuticals | Meals · 2025-06-04 | Nuzyra | $25 |
| Stryker | Meals · 2025-05-13 | Ortholoc 2 Lapifuse | $28 |
| Smith+Nephew | Meals · 2025-05-07 | Grafix | $125 |
| Alafair Biosciences | Meals · 2025-05-06 | Versawrap | $28 |
| Amgen | Meals · 2025-04-15 | Krystexxa | $30 |
| Amgen | Meals · 2025-04-08 | Krystexxa | $125 |
| Amgen | Meals · 2025-04-04 | Krystexxa | $9 |
| Amgen | Meals · 2025-03-20 | Krystexxa | $8 |
| Smith+Nephew | Meals · 2025-03-18 | Stravix | $46 |
| Vertex Pharmaceuticals | Meals · 2025-03-13 | Journavx | $17 |
| Avita Medical Americas | Meals · 2025-03-11 | Recell | $135 |
| Smith+Nephew | Meals · 2025-02-26 | Stravix | $39 |
| Paratek Pharmaceuticals | Meals · 2025-01-21 | Nuzyra | $14 |
| DePuy Synthes Sales | Meals · 2025-01-14 | Motoband | $93 |
| Curonix | Meals · 2025-01-07 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A | $111 |
| DePuy Synthes Sales | Meals · 2025-01-03 | Motoband | $50 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $2,055
| Stryker | Augment Injectable | $415 | 3 payments
|
| Alafair Biosciences | Versawrap | $326 | 3 payments
|
| Smith+Nephew | Grafix | $229 | 7 payments
|
| Exactech | Vantage | $213 | 1 payment
|
| Kerecis | Kerecis Omega3 Surgiclose | $196 | 2 payments
|
| Averitas Pharma | Qutenza | $195 | 3 payments
|
| Treace Medical Concepts | Lapiplasty System | $190 | 1 payment
|
| Biotissue Holdings | None | $103 | 4 payments
|
| DePuy Synthes Sales | Motoband | $89 | 2 payments
|
| Amgen | Krystexxa | $45 | 2 payments
|
| Avita Medical Americas | Recell | $20 | 1 payment
|
| Vertex Pharmaceuticals | None | $17 | 1 payment
|
| Paratek Pharmaceuticals | Nuzyra | $17 | 1 payment
|
2023: $2,201
| Arthrex | None | $1,202 | 10 payments
|
| Nevro | Senza | $196 | 3 payments
|
| Smith+Nephew | Bioinductive Implant With Arthroscopic Delivery System - Medium | $166 | 6 payments
|
| Organogenesis | Puraply | $152 | 2 payments
|
| Paratek Pharmaceuticals | Nuzyra | $147 | 3 payments
|
| Linvatec | Fracture and Correction Colag 2 | $112 | 1 payment
|
| Paragon 28 | Mtp | $108 | 2 payments
|
| Biotissue Holdings | Neox | $41 | 3 payments
|
| Evolution Surgical | None | $40 | 1 payment
|
| Horizon Therapeutics plc | Krystexxa | $20 | 1 payment
|
| Musculoskeletal Transplant Foundation | None | $16 | 1 payment
|
2022: $1,129
| Smith+Nephew | Stravix | $356 | 10 payments
|
| Nevro | Omnia | $225 | 2 payments
|
| Zimmer Biomet Holdings | Stratum Foot Plating System | $183 | 2 payments
|
| BioTissue Holdings | Neox | $121 | 1 payment
|
| Paratek Pharmaceuticals | Nuzyra | $117 | 1 payment
|
| Musculoskeletal Transplant Foundation | None | $74 | 1 payment
|
| Stryker | Gravity | $37 | 1 payment
|
| Paragon 28 | Grappler | $16 | 1 payment
|
2021: $412
| Treace Medical Concepts | Lapiplasty System | $158 | 1 payment
|
| Paratek Pharmaceuticals | Nuzyra | $143 | 2 payments
|
| Smith+Nephew | Grafix | $112 | 8 payments
|
2020: $906
| Musculoskeletal Transplant Foundation | None | $220 | 1 payment
|
| Smith+Nephew | Grafix Pl | $196 | 9 payments
|
| Zimmer Biomet Holdings | Stratum Foot Plating System | $107 | 1 payment
|
| Wright Medical Technology | Ortholoc | $100 | 1 payment
|
| Integra LifeSciences | Salto Talaris Total Ankle Prosthesis | $74 | 3 payments
|
| Horizon Therapeutics plc | Krystexxa | $47 | 2 payments
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $44 | 1 payment
|
| Organogenesis | Puraply | $44 | 2 payments
|
| Evolution Surgical | None | $27 | 1 payment
|
| Amniox Medical | Neox | $25 | 1 payment
|
| Fidia Pharma USA | Nudyn | $24 | 1 payment
|
2019: $1,884
| Smith+Nephew | Grafix Pl Prime | $442 | 20 payments
|
| Integra LifeSciences | Salto Talaris Total Ankle Prosthesis | $399 | 13 payments
|
| Medical Device Business Services | VA-Lcp Plates & Screws | $339 | 4 payments
|
| DePuy Synthes Sales | Bme Nitinol Continuous Compression Implants | $114 | 2 payments
|
| Medline Industries | None | $105 | 1 payment
|
| Paragon 28 | None | $84 | 2 payments
|
| Osiris Therapeutics | Stravix | $77 | 1 payment
|
| Horizon Therapeutics plc | Krystexxa | $73 | 3 payments
|
| Evolution Surgical | None | $56 | 1 payment
|
| Wright Medical Technology | Ortholoc | $49 | 3 payments
|
| Zyla Life Sciences | Sprix | $44 | 3 payments
|
| Melinta Therapeutics | Baxdela | $34 | 1 payment
|
| Bioventus | Exogen | $33 | 1 payment
|
| Fidia Pharma USA | Nudyn | $23 | 1 payment
|
| Arthrosurface | Alignmate | $13 | 1 payment
|
Checkups this office reported
1 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 75.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Patients can see their records onlinePatients who were given electronic access to their health information | 98%That's most of the people this applied to. | 675 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Did a security review of patient data
- Exchanges records both ways with other health systems
- Implementation of fall screening and assessment programs
- Implementation of medication management practice improvements
- Improved the patient portal
- Lets patients read their visit notes
- ONC-ACB Surveillance Attestation
- Reports cases to public health electronically
- Reports to a public-health or clinical registry
- Uses standard treatment protocols
- Exempt from e-prescribing
- Exempt from immunization registry reporting
- Exempt from query of the prescription drug monitoring program (pdmp)
Professional record
- NPI
- 1023112554
- Licence
- CA E4147
- Trained
- California School of Podiatric Medicine, 1996
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 213ES0103X (213ES0103X)
- Mailing address
- 2577 Samaritan Dr Ste 840, San Jose, CA, 95124
- NPI first listed
- 2006-09-13
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.